Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
2012 2
2013 1
2014 1
2015 1
2017 2
2018 1
2019 2
2020 3
2021 11
2022 6
2023 7
2024 7
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication.
Matricardi S, Cestèle S, Trivisano M, Kassabian B, Leroudier N, Vittorini R, Nosadini M, Cesaroni E, Siliquini S, Marinaccio C, Longaretti F, Podestà B, Operto FF, Luisi C, Sartori S, Boniver C, Specchio N, Vigevano F, Marini C, Mantegazza M. Matricardi S, et al. Among authors: luisi c. Epilepsia. 2023 May;64(5):1331-1347. doi: 10.1111/epi.17509. Epub 2023 Jan 26. Epilepsia. 2023. PMID: 36636894 Review.
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study.
Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) Group Membership. Lattanzi S, et al. Neurol Ther. 2025 Jun;14(3):775-786. doi: 10.1007/s40120-025-00717-x. Epub 2025 Mar 12. Neurol Ther. 2025. PMID: 40069539 Free PMC article.
Juvenile myoclonic epilepsy: Long-term prognosis and risk factors.
Pietrafusa N, La Neve A, de Palma L, Boero G, Luisi C, Vigevano F, Specchio N. Pietrafusa N, et al. Among authors: luisi c. Brain Dev. 2021 Jun;43(6):688-697. doi: 10.1016/j.braindev.2021.02.005. Epub 2021 Mar 27. Brain Dev. 2021. PMID: 33781581 Review.
Verb generation for presurgical mapping: Gaining specificity.
Salillas E, Luisi C, Arcara G, Varlı EN, d'Avella D, Semenza C. Salillas E, et al. Among authors: luisi c. J Neuropsychol. 2024 Mar;18 Suppl 1:183-204. doi: 10.1111/jnp.12355. Epub 2023 Dec 7. J Neuropsychol. 2024. PMID: 38062895
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures.
Lattanzi S, Ascoli M, Canafoglia L, Paola Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group. Lattanzi S, et al. Epilepsia. 2022 May;63(5):e42-e50. doi: 10.1111/epi.17223. Epub 2022 Mar 26. Epilepsia. 2022. PMID: 35278335 Free PMC article.
42 results